Your browser doesn't support javascript.
loading
Association between control group therapy and magnitude of clinical benefit of cancer drugs.
Molto, Consolacion; Tibau, Ariadna; Bujosa, Aida; Tapia, Jose Carlos; Mittal, Abhenil; Tamimi, Faris; Amir, Eitan.
Afiliação
  • Molto C; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada.
  • Tibau A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Department of Medicine of Universitat Autònoma de Barcelona, Institut d'investigacio Biomedica Sant Pau, Barcelona, Catalonia, Spain.
  • Bujosa A; Medical Oncology Department, Hospital Son Llàtzer, Palma de Mallorca, Balearic Islands, Spain.
  • Tapia JC; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Department of Medicine of Universitat Autònoma de Barcelona, Institut d'investigacio Biomedica Sant Pau, Barcelona, Catalonia, Spain.
  • Mittal A; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada.
  • Tamimi F; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada.
  • Amir E; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. eitan.amir@uhn.ca.
Sci Rep ; 12(1): 21342, 2022 12 09.
Article em En | MEDLINE | ID: mdl-36494465

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá